| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 18.112 | 43.232 | 57.126 | 54.380 | 52.389 |
| Total Income - EUR | - | - | - | - | - | 18.112 | 43.232 | 57.126 | 54.380 | 52.389 |
| Total Expenses - EUR | - | - | - | - | - | 9.177 | 11.763 | 12.581 | 11.723 | 15.808 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.936 | 31.469 | 44.545 | 42.656 | 36.581 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.397 | 30.331 | 43.133 | 42.214 | 35.009 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Helen Gynmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 11.058 | 5.171 | 2.522 | 3.471 | 4.434 |
| Current Assets | - | - | - | - | - | 35.498 | 28.208 | 42.031 | 54.434 | 37.970 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.884 | 21.724 | 36.384 | 7.739 | 28.249 |
| Cash | - | - | - | - | - | 33.614 | 6.484 | 5.647 | 46.695 | 9.721 |
| Shareholders Funds | - | - | - | - | - | 20.167 | 30.371 | 43.173 | 55.820 | 35.049 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 26.388 | 3.008 | 1.379 | 2.085 | 7.355 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Helen Gynmed S.r.l.